Usefulness of a novel diagnostic method of tuberculosis infection, QuantiFERON® TB-2G, in an outbreak of tuberculosis

Kekkaku

Volumn 79, Issue 11, 2004, Pages 637-643

  Harada, Nobuyuki ^a   Mori, Toru ^a   Shishido, Shinji ^a   Higuchi, Kazue ^a   Sekiya, Yukie ^a  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

Chemoprophylaxis; Latent tuberculosis infection; Tuberculin skin test; Tuberculosis outbreak; Whole blood interferon gamma assay

Indexed keywords

ANTIGEN; BCG VACCINE; GAMMA INTERFERON;

ALLERGY; ARTICLE; BACTERIAL TRANSMISSION; BCG VACCINATION; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COLLEGE STUDENT; CORRELATION ANALYSIS; COUGHING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ERYTHEMA; HUMAN; JAPAN; MAJOR CLINICAL STUDY; SPUTUM SMEAR; TREATMENT INDICATION; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; ANTIGENS, BACTERIAL; CONTACT TRACING; DISEASE OUTBREAKS; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 13444270644     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Streeton JA, Desem N, Jones SL: Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis. 1998; 2: 443-450.
2. Andersen P, Munk ME, Pollock JM, et al.: Specific immune-based diagnosis of tuberculosis. Lancet. 2000; 356: 1099-1104.
3. Mori T, Sakatani M, Yamagishi F, et al.: Specific detection of tuberculosis infection with an interferon-gamma based assay using new antigens. Am J Respir Crit Care Med. 2004; 170: 59-64.
4. Hirsch CS, Toossi Z, Othieno C, et al.: Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis. 1999; 180: 2069-2073.
5. Pathan AA, Wilkinson KA, Klenerman P, et al.: Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol. 2001; 167: 5217-5225.
6. Vekemans J, Lienhardt C, Sillah JS, et al.: Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun. 2001; 69: 6554-6557.
7. Brock I, Weldingh K, Lillebaek T, et al.: Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med. 2004; 170: 65-69.
8. Ewer K, Deeks J, Alvarez L, et al.: Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003; 361: 1168-1173.
9. Arend SM, van Meijgaarden KE, de Boer K, et al.: Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis. 2002; 186: 1797-1807.
10. ATS/CDC Statement Committee on Latent Tuberculosis Infection: Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000/49 (RR06); 1-54, 2000